Attorney Seeks $1 Billion In Punitive Damages In Hep C Propofol Trial

The attorney for the lead plaintiff in the case against two drug companies found liable for a Las Vegas man’s hepatitis C infection asked jurors Thursday to award more than $1 billion in punitive damages, saying their verdict should make a statement against putting corporate profits ahead of patient safety.

Robert Eglet, who represents 62-year-old Henry Chanin, called the amount “the most historically large sum of money ever asked for in any courthouse anywhere in the state of Nevada.” He asked jurors to assign $616,204,974 in punitive damages to Teva Parenteral Medicines Inc., and $419,855,051 to Baxter Healthcare Corp., to send the companies a message and force them to change their practices in manufacturing and distributing the drug propofol, an anesthetic.

FULL STORY HERE

UPDATE: The Clark County District Court jury in Nevada ordered Teva to pay $356 million and Baxter to pay $144 million in the largest jury award in Nevada history, attorney Robert Eglet said.

email
Share

Related Posts

  1. Juries Slap Propofol Companies With Over $280M Damages In Hep C Cases
  2. Second Hepatitis C Trial Underway Against Propofol Maker
  3. Winkler Prosecutor Seeks Change of Venue For Trial of Sheriff
  4. CRNA Defense Lawyer Seeks Delay In Nevada Hep C Propofol Trial
  5. Plaintiff Awarded More Than $500m In Propofol Hepatitis C Lawsuit
Tags: , , , , ,

3 Responses to Attorney Seeks $1 Billion In Punitive Damages In Hep C Propofol Trial

  1. [...] informed the FDA they will no longer manufacture propofol…..and a shortage already exists. Huge Lawsuit Damages, Poor Manufacturing Quality Control, FDA Warnings to shape up their manufacturing plant or face [...]

  2. [...] previously reported on the record breaking $500 million jury award for Henry Chanin, who contracted Hepatitis C from [...]

  3. [...] previously discussed the case of Henry Chanin, 62, who sued Teva Parenteral Medicines Inc. and Baxter Healthcare Corp., the two companies that [...]

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>